The journals of gerontology. Series A, Biological sciences and medical sciences
Liraglutide improves cognitive function by reducing amyloid-beta peptide accumulation and inhibiting inflammation in 5 × FAD mice.
Liqin Qi, Lijing Lin, Jiaping Zheng, Xiaoying Liu, Xiaohong Liu, Zhou Chen, Libin Liu
Published: 202510.1093/gerona/glaf265
Abstract
Alzheimer's disease (AD) is a degenerative disease of the central nervous system characterized by progressive memory decline. The increasing prevalence of AD has attracted considerable attention globally. The glucagon-like peptide-1 analog, liragluti…
Preview only. Read the full abstract at the source